Dr Reddy's Laboratories Stock | DRREDDY.NS | INE089A01023 | 659157

Date	Dr Reddy's Laboratories Price
9/20/2024	6,551.15 undefined
9/19/2024	6,502.55 undefined
9/18/2024	6,567.80 undefined
9/17/2024	6,631.65 undefined
9/16/2024	6,647.10 undefined
9/13/2024	6,660.70 undefined
9/12/2024	6,663.70 undefined
9/11/2024	6,612.50 undefined
9/10/2024	6,650.40 undefined
9/9/2024	6,655.90 undefined
9/6/2024	6,667.15 undefined
9/5/2024	6,700.00 undefined
9/4/2024	6,787.20 undefined
9/3/2024	6,853.85 undefined
9/2/2024	6,872.15 undefined
8/30/2024	7,031.35 undefined
8/29/2024	6,931.15 undefined
8/28/2024	6,998.60 undefined
8/27/2024	6,962.95 undefined
8/26/2024	6,943.30 undefined

Date	Dr Reddy's Laboratories Revenue	Dr Reddy's Laboratories EBIT	Dr Reddy's Laboratories Net Income
2028e	372.73 B undefined	85.85 B undefined	0 undefined
2027e	331.63 B undefined	59.22 B undefined	49.59 B undefined
2026e	340.53 B undefined	73.72 B undefined	60.73 B undefined
2025e	314.89 B undefined	71.39 B undefined	58.23 B undefined
2024	280.11 B undefined	64.63 B undefined	55.78 B undefined
2023	246.7 B undefined	52.9 B undefined	45.07 B undefined
2022	215.45 B undefined	35.33 B undefined	21.83 B undefined
2021	190.48 B undefined	33.22 B undefined	19.52 B undefined
2020	175.17 B undefined	29.91 B undefined	20.26 B undefined
2019	154.48 B undefined	20.55 B undefined	19.5 B undefined
2018	142.81 B undefined	12.74 B undefined	9.47 B undefined
2017	141.96 B undefined	14.9 B undefined	12.92 B undefined
2016	155.68 B undefined	30.8 B undefined	21.31 B undefined
2015	150.23 B undefined	27.48 B undefined	23.36 B undefined
2014	134.15 B undefined	26.03 B undefined	19.63 B undefined
2013	118.96 B undefined	21.73 B undefined	15.27 B undefined
2012	98.15 B undefined	19.17 B undefined	13.01 B undefined
2011	74.97 B undefined	11.55 B undefined	9.99 B undefined
2010	70.31 B undefined	10.14 B undefined	3.52 B undefined
2009	69.01 B undefined	9.56 B undefined	-9.17 B undefined
2008	49.92 B undefined	4.39 B undefined	4.38 B undefined
2007	65.26 B undefined	12.85 B undefined	9.66 B undefined
2006	23.63 B undefined	1.52 B undefined	1.47 B undefined
2005	18.42 B undefined	-332 M undefined	329 M undefined

	Revenue	EBIT	Net Income
2005	18.42 B INR	-332 M INR	329 M INR
2006	23.63 B INR	1.52 B INR	1.47 B INR
2007	65.26 B INR	12.85 B INR	9.66 B INR
2008	49.92 B INR	4.39 B INR	4.38 B INR
2009	69.01 B INR	9.56 B INR	-9.17 B INR
2010	70.31 B INR	10.14 B INR	3.52 B INR
2011	74.97 B INR	11.55 B INR	9.99 B INR
2012	98.15 B INR	19.17 B INR	13.01 B INR
2013	118.96 B INR	21.73 B INR	15.27 B INR
2014	134.15 B INR	26.03 B INR	19.63 B INR
2015	150.23 B INR	27.48 B INR	23.36 B INR
2016	155.68 B INR	30.8 B INR	21.31 B INR
2017	141.96 B INR	14.9 B INR	12.92 B INR
2018	142.81 B INR	12.74 B INR	9.47 B INR
2019	154.48 B INR	20.55 B INR	19.5 B INR
2020	175.17 B INR	29.91 B INR	20.26 B INR
2021	190.48 B INR	33.22 B INR	19.52 B INR
2022	215.45 B INR	35.33 B INR	21.83 B INR
2023	246.7 B INR	52.9 B INR	45.07 B INR
2024	280.11 B INR	64.63 B INR	55.78 B INR
2025e	314.89 B INR	71.39 B INR	58.23 B INR
2026e	340.53 B INR	73.72 B INR	60.73 B INR
2027e	331.63 B INR	59.22 B INR	49.59 B INR
2028e	372.73 B INR	85.85 B INR	0 INR

Dr Reddy's Laboratories Gross margin	Dr Reddy's Laboratories Profit margin	Dr Reddy's Laboratories EBIT margin	Dr Reddy's Laboratories Profit margin
2028e	68.08 %	23.03 %	0 %
2027e	68.08 %	17.86 %	14.95 %
2026e	68.08 %	21.65 %	17.83 %
2025e	68.08 %	22.67 %	18.49 %
2024	68.08 %	23.07 %	19.91 %
2023	66.34 %	21.44 %	18.27 %
2022	62.88 %	16.4 %	10.13 %
2021	65.54 %	17.44 %	10.25 %
2020	65.68 %	17.07 %	11.57 %
2019	67.77 %	13.3 %	12.62 %
2018	68.35 %	8.92 %	6.63 %
2017	70.36 %	10.5 %	9.1 %
2016	71.33 %	19.78 %	13.69 %
2015	70.7 %	18.29 %	15.55 %
2014	68.7 %	19.41 %	14.63 %
2013	66.57 %	18.26 %	12.83 %
2012	69.75 %	19.53 %	13.25 %
2011	69.2 %	15.41 %	13.32 %
2010	63.7 %	14.42 %	5 %
2009	62.89 %	13.86 %	-13.29 %
2008	63.04 %	8.79 %	8.78 %
2007	56.21 %	19.69 %	14.8 %
2006	63.27 %	6.42 %	6.21 %
2005	66.01 %	-1.8 %	1.79 %

	Gross margin	EBIT margin	Profit margin
2005	66.01 %	-1.8 %	1.79 %
2006	63.27 %	6.42 %	6.21 %
2007	56.21 %	19.69 %	14.8 %
2008	63.04 %	8.79 %	8.78 %
2009	62.89 %	13.86 %	-13.29 %
2010	63.7 %	14.42 %	5 %
2011	69.2 %	15.41 %	13.32 %
2012	69.75 %	19.53 %	13.25 %
2013	66.57 %	18.26 %	12.83 %
2014	68.7 %	19.41 %	14.63 %
2015	70.7 %	18.29 %	15.55 %
2016	71.33 %	19.78 %	13.69 %
2017	70.36 %	10.5 %	9.1 %
2018	68.35 %	8.92 %	6.63 %
2019	67.77 %	13.3 %	12.62 %
2020	65.68 %	17.07 %	11.57 %
2021	65.54 %	17.44 %	10.25 %
2022	62.88 %	16.4 %	10.13 %
2023	66.34 %	21.44 %	18.27 %
2024	68.08 %	23.07 %	19.91 %
2025e	68.08 %	22.67 %	18.49 %
2026e	68.08 %	21.65 %	17.83 %
2027e	68.08 %	17.86 %	14.95 %
2028e	68.08 %	23.03 %	0 %

Date	Dr Reddy's Laboratories Sales per Share	Dr Reddy's Laboratories EBIT per share	Dr Reddy's Laboratories Earnings per Share
2028e	2,237.6 undefined	0 undefined	0 undefined
2027e	1,990.83 undefined	0 undefined	297.71 undefined
2026e	2,044.25 undefined	0 undefined	364.59 undefined
2025e	1,890.36 undefined	0 undefined	349.58 undefined
2024	1,680.25 undefined	387.71 undefined	334.59 undefined
2023	1,482.66 undefined	317.92 undefined	270.89 undefined
2022	1,295.26 undefined	212.39 undefined	131.21 undefined
2021	1,147.44 undefined	200.13 undefined	117.57 undefined
2020	1,055.24 undefined	180.16 undefined	122.05 undefined
2019	930.61 undefined	123.8 undefined	117.47 undefined
2018	860.3 undefined	76.75 undefined	57.04 undefined
2017	850.07 undefined	89.23 undefined	77.37 undefined
2016	910.43 undefined	180.11 undefined	124.6 undefined
2015	878.56 undefined	160.71 undefined	136.63 undefined
2014	784.52 undefined	152.24 undefined	114.81 undefined
2013	695.65 undefined	127.06 undefined	89.29 undefined
2012	577.32 undefined	112.76 undefined	76.52 undefined
2011	440.99 undefined	67.95 undefined	58.76 undefined
2010	413.59 undefined	59.62 undefined	20.68 undefined
2009	410.75 undefined	56.91 undefined	-54.6 undefined
2008	295.37 undefined	25.96 undefined	25.92 undefined
2007	407.85 undefined	80.32 undefined	60.37 undefined
2006	153.42 undefined	9.86 undefined	9.53 undefined
2005	120.4 undefined	-2.17 undefined	2.15 undefined

	Sales per Share	EBIT per share	Earnings per Share
2005	120.4 INR	-2.17 INR	2.15 INR
2006	153.42 INR	9.86 INR	9.53 INR
2007	407.85 INR	80.32 INR	60.37 INR
2008	295.37 INR	25.96 INR	25.92 INR
2009	410.75 INR	56.91 INR	-54.6 INR
2010	413.59 INR	59.62 INR	20.68 INR
2011	440.99 INR	67.95 INR	58.76 INR
2012	577.32 INR	112.76 INR	76.52 INR
2013	695.65 INR	127.06 INR	89.29 INR
2014	784.52 INR	152.24 INR	114.81 INR
2015	878.56 INR	160.71 INR	136.63 INR
2016	910.43 INR	180.11 INR	124.6 INR
2017	850.07 INR	89.23 INR	77.37 INR
2018	860.3 INR	76.75 INR	57.04 INR
2019	930.61 INR	123.8 INR	117.47 INR
2020	1,055.24 INR	180.16 INR	122.05 INR
2021	1,147.44 INR	200.13 INR	117.57 INR
2022	1,295.26 INR	212.39 INR	131.21 INR
2023	1,482.66 INR	317.92 INR	270.89 INR
2024	1,680.25 INR	387.71 INR	334.59 INR
2025e	1,890.36 INR	0 INR	349.58 INR
2026e	2,044.25 INR	0 INR	364.59 INR
2027e	1,990.83 INR	0 INR	297.71 INR
2028e	2,237.6 INR	0 INR	0 INR

	Number of stocks
2005	153 M Aktien
2006	154 M Aktien
2007	160 M Aktien
2008	169 M Aktien
2009	168 M Aktien
2010	170 M Aktien
2011	170 M Aktien
2012	170 M Aktien
2013	171 M Aktien
2014	171 M Aktien
2015	171 M Aktien
2016	171 M Aktien
2017	167 M Aktien
2018	166 M Aktien
2019	166 M Aktien
2020	166 M Aktien
2021	166 M Aktien
2022	166.34 M Aktien
2023	166.39 M Aktien
2024	166.71 M Aktien
2025e	166.71 M Aktien
2026e	166.71 M Aktien
2027e	166.71 M Aktien
2028e	166.71 M Aktien

Date	Dr Reddy's Laboratories Dividend
2028e	43.55 undefined
2027e	43.55 undefined
2026e	43.55 undefined
2025e	43.54 undefined
2024	40 undefined
2023	40 undefined
2022	30 undefined
2021	25 undefined
2020	25 undefined
2019	20 undefined
2018	20 undefined
2017	20 undefined
2016	20 undefined
2015	20 undefined
2014	18 undefined
2013	15 undefined
2012	13.75 undefined
2011	11.25 undefined
2010	11.25 undefined
2009	6.25 undefined
2008	3.75 undefined
2007	3.75 undefined
2006	2.5 undefined
2005	2.5 undefined

	Dividend	Dividend (Estimate)
2005	2.5 INR	0 INR
2006	2.5 INR	0 INR
2007	3.75 INR	0 INR
2008	3.75 INR	0 INR
2009	6.25 INR	0 INR
2010	11.25 INR	0 INR
2011	11.25 INR	0 INR
2012	13.75 INR	0 INR
2013	15 INR	0 INR
2014	18 INR	0 INR
2015	20 INR	0 INR
2016	20 INR	0 INR
2017	20 INR	0 INR
2018	20 INR	0 INR
2019	20 INR	0 INR
2020	25 INR	0 INR
2021	25 INR	0 INR
2022	30 INR	0 INR
2023	40 INR	0 INR
2024	40 INR	0 INR
2025e	0 INR	43.54 INR
2026e	0 INR	43.55 INR
2027e	0 INR	43.55 INR
2028e	0 INR	43.55 INR

Date	Dr Reddy's Laboratories Payout ratio
2028e	21.96 %
2027e	21.94 %
2026e	21.84 %
2025e	22.1 %
2024	21.89 %
2023	21.54 %
2022	22.87 %
2021	21.27 %
2020	20.49 %
2019	17.03 %
2018	35.07 %
2017	25.85 %
2016	16.05 %
2015	14.64 %
2014	15.68 %
2013	16.8 %
2012	17.97 %
2011	19.15 %
2010	54.37 %
2009	-11.45 %
2008	14.47 %
2007	6.21 %
2006	26.21 %
2005	116.28 %

	Payout ratio
2005	116.28 %
2006	26.21 %
2007	6.21 %
2008	14.47 %
2009	-11.45 %
2010	54.37 %
2011	19.15 %
2012	17.97 %
2013	16.8 %
2014	15.68 %
2015	14.64 %
2016	16.05 %
2017	25.85 %
2018	35.07 %
2019	17.03 %
2020	20.49 %
2021	21.27 %
2022	22.87 %
2023	21.54 %
2024	21.89 %
2025e	22.1 %
2026e	21.84 %
2027e	21.94 %
2028e	21.96 %

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2024	78.23	83.48 (6.71 %)	2025 Q1
3/31/2024	74.75	78.35 (4.81 %)	2024 Q4
12/31/2023	75.42	82.81 (9.8 %)	2024 Q3
9/30/2023	73.94	88.91 (20.25 %)	2024 Q2
6/30/2023	61.96	84.36 (36.15 %)	2024 Q1
3/31/2023	48.97	57.68 (17.78 %)	2023 Q4
12/31/2022	66.02	74.76 (13.23 %)	2023 Q3
9/30/2022	48.14	66.98 (39.15 %)	2023 Q2
6/30/2022	38.84	71.49 (84.05 %)	2023 Q1
3/31/2022	40.45	5.83 (-85.59 %)	2022 Q4
12/31/2021	44.86	42.48 (-5.31 %)	2022 Q3
9/30/2021	41.06	59.65 (45.28 %)	2022 Q2
6/30/2021	40.22	34.34 (-14.61 %)	2022 Q1
3/31/2021	39.75	33.29 (-16.25 %)	2021 Q4
12/31/2020	44	1.19 (-97.3 %)	2021 Q3
9/30/2020	37.23	45.83 (23.09 %)	2021 Q2
6/30/2020	30.97	34.86 (12.57 %)	2021 Q1
3/31/2020	32.79	46.05 (40.44 %)	2020 Q4
12/31/2019	29.97	-34.37 (-214.68 %)	2020 Q3
9/30/2019	34.31	65.82 (91.86 %)	2020 Q2
6/30/2019	27.91	39.91 (42.99 %)	2020 Q1
3/31/2019	24.46	26.16 (6.95 %)	2019 Q4
12/31/2018	23.5	29.21 (24.29 %)	2019 Q3
9/30/2018	21.25	30.31 (42.61 %)	2019 Q2
6/30/2018	18.63	27.45 (47.38 %)	2019 Q1
3/31/2018	22.4	16.36 (-26.97 %)	2018 Q4
12/31/2017	19.75	18.22 (-7.76 %)	2018 Q3
9/30/2017	17.39	18.39 (5.75 %)	2018 Q2
6/30/2017	21.07	4.01 (-80.97 %)	2018 Q1
3/31/2017	26.84	20.34 (-24.22 %)	2017 Q4
12/31/2016	23.83	29.65 (24.44 %)	2017 Q3
9/30/2016	23.08	18.59 (-19.45 %)	2017 Q2
6/30/2016	29.35	9.03 (-69.23 %)	2017 Q1
3/31/2016	36.25	4.36 (-87.97 %)	2016 Q4
12/31/2015	39.73	33.86 (-14.78 %)	2016 Q3
9/30/2015	39.02	42.2 (8.16 %)	2016 Q2
6/30/2015	33.78	36.58 (8.28 %)	2016 Q1
3/31/2015	35.38	30.35 (-14.22 %)	2015 Q4
12/31/2014	35.39	33.61 (-5.04 %)	2015 Q3
9/30/2014	33.56	33.6 (0.12 %)	2015 Q2
6/30/2014	32.46	32.24 (-0.67 %)	2015 Q1
3/31/2014	35.83	28.22 (-21.24 %)	2014 Q4
12/31/2013	30.53	25.31 (-17.1 %)	2014 Q3
9/30/2013	27.2	40.47 (48.81 %)	2014 Q2
6/30/2013	26.67	21.17 (-20.63 %)	2014 Q1
3/31/2013	27.86	33.51 (20.29 %)	2013 Q4
12/31/2012	28.44	21.33 (-25.01 %)	2013 Q3
9/30/2012	25.19	29 (15.09 %)	2013 Q2
6/30/2012	25.81	19.74 (-23.51 %)	2013 Q1
3/31/2012	26.06	24.88 (-4.5 %)	2012 Q4
12/31/2011	22.94	30.16 (31.47 %)	2012 Q3
9/30/2011	16.76	18.1 (7.99 %)	2012 Q2
6/30/2011	15.73	15.45 (-1.76 %)	2012 Q1
3/31/2011	15.04	19.68 (30.83 %)	2011 Q4
12/31/2010	18.57	16.1 (-13.32 %)	2011 Q3
9/30/2010	15.27	16.88 (10.57 %)	2011 Q2
6/30/2010	15.04	12.34 (-17.93 %)	2011 Q1
3/31/2010	13.32	6.23 (-53.25 %)	2010 Q4
12/31/2009	15.03	13.34 (-11.22 %)	2010 Q3
9/30/2009	7.49	14.12 (88.42 %)	2010 Q2
6/30/2009	31.62	14.18 (-55.16 %)	2010 Q1
3/31/2009	13.51	-9.41 (-169.6 %)	2009 Q4
12/31/2008	8.05	9.45 (17.44 %)	2009 Q3
9/30/2008	8.46	5.15 (-39.17 %)	2009 Q2
6/30/2008	11.22	5.47 (-51.25 %)	2009 Q1
3/31/2008	7.14	4.62 (-35.32 %)	2008 Q4
12/31/2007	8.67	3.72 (-57.09 %)	2008 Q3
9/30/2007	7.75	6.58 (-15.12 %)	2008 Q2
6/30/2007	12.24	11.15 (-8.91 %)	2008 Q1
3/31/2007	14.44	26.92 (86.44 %)	2007 Q4
12/31/2006	12.26	6.62 (-46 %)	2007 Q3
9/30/2006	10.91	19.06 (74.66 %)	2007 Q2
6/30/2006	5.91	8.41 (42.18 %)	2007 Q1
3/31/2006	2.81	-2.52 (-189.61 %)	2006 Q4
12/31/2005	3.81	4.17 (9.21 %)	2006 Q3
9/30/2005	3.12	5.94 (90.43 %)	2006 Q2
6/30/2005	3.5	2 (-43.07 %)	2006 Q1
3/31/2005	1.98	-1.76 (-188.46 %)	2005 Q4
12/31/2004	3.81	-0.23 (-106.03 %)	2005 Q3
9/30/2004	3.06	3.07 (0.21 %)	2005 Q2

%	Name	Stocks	Change	Date
5.16830 %	Life Insurance Corporation of India	8,609,240	-719,727	12/31/2023
3.31598 %	Reddy (Satish K) HUF	5,523,677	0	12/31/2023
20.61819 %	APS Trust	34,345,308	0	12/31/2023
2.51998 %	Stewart Investors	4,197,731	129,609	9/30/2023
2.18940 %	NPS Trust	3,647,059	158,214	12/31/2023
15.35356 %	JPMorgan Asset Management (Asia Pacific) Limited	25,575,599	2,197,765	12/31/2023
1.98252 %	BlackRock Institutional Trust Company, N.A.	3,302,440	107,533	3/31/2024
1.90916 %	The Vanguard Group, Inc.	3,180,235	0	3/31/2024
1.81291 %	HDFC Asset Management Co., Ltd.	3,019,901	-133,188	12/31/2023
1.52687 %	Prasad (G V) HUF	2,543,418	0	12/31/2023
1.46142 %	SBI Funds Management Pvt. Ltd.	2,434,395	-357,795	12/31/2023
1.06962 %	GIC Private Limited	1,781,751	-232,588	12/31/2023
0.98073 %	APG Asset Management N.V.	1,633,679	709,484	9/30/2023
0.95992 %	ICICI Prudential Asset Management Co. Ltd.	1,599,012	2,454	3/31/2024
0.94386 %	Geode Capital Management, L.L.C.	1,572,261	31,499	3/31/2024
0.92540 %	Norges Bank Investment Management (NBIM)	1,541,502	-218,378	12/31/2023
0.78503 %	UTI Asset Management Co. Ltd.	1,307,679	20,332	3/31/2024
0.67266 %	Kallam (Samrajyam Reddy)	1,120,499	0	12/31/2023
0.64989 %	BlackRock Advisors (UK) Limited	1,082,579	34,752	3/31/2024
0.63656 %	PPFAS Asset Management Private Limited	1,060,364	107,432	3/31/2024
0.61750 %	RBC Global Asset Management (UK) Limited	1,028,614	-6,671	2/29/2024
0.61648 %	Nippon Life India Asset Management Limited	1,026,914	25,758	3/31/2024
0.54089 %	Reddy (Satish K)	901,002	0	12/31/2023
0.36963 %	Tata Asset Management Ltd.	615,725	608	3/31/2024
0.33115 %	Kotak Mahindra Asset Management Company Limited	551,617	7,221	3/31/2024
0.30313 %	RWC Asset Advisors (US) LLC	504,944	123,387	2/29/2024
0.29246 %	Bandhan Asset Management Company Limited	487,166	12,424	3/31/2024
0.29199 %	Aikya Investment Management Limited	486,390	1,895	9/30/2023
0.26650 %	First Sentier Investors (Hong Kong) Limited	443,922	-11,530	10/31/2023
0.26319 %	First Sentier Investments (U.K.) Ltd	438,408	0	9/30/2023
0.22168 %	Dimensional Fund Advisors, L.P.	369,262	1,809	3/31/2024
0.20701 %	Mellon Investments Corporation	344,829	13,052	3/31/2024
0.18887 %	Nuveen LLC	314,614	0	3/31/2024
0.18764 %	Mirae Asset Global Investments (India) Pvt. Ltd.	312,562	-5,008	3/31/2024
0.16396 %	JPMorgan Asset Management U.K. Limited	273,126	3,322	2/29/2024
0.15008 %	Canara Robeco Asset Management Company Ltd.	250,000	0	3/31/2024
0.14967 %	Lazard Asset Management, L.L.C.	249,325	0	3/31/2024
0.14355 %	Sundaram Asset Management Company Limited	239,124	10,123	3/31/2024
0.13913 %	State Street Global Advisors (UK) Ltd.	231,754	1	3/31/2024
0.12412 %	Aviva Investors Global Services Limited	206,755	41,176	2/29/2024
0.11857 %	Northern Trust Global Investments Limited	197,516	9,521	2/29/2024
0.10051 %	Federated Hermes International	167,433	0	3/31/2024
0.09755 %	Jupiter Asset Management Ltd.	162,499	2,435	12/31/2023
0.08904 %	Charles Schwab Investment Management, Inc.	148,328	-4,235	3/31/2024
0.08798 %	DWS Investments UK Limited	146,549	9,989	3/31/2024
0.08736 %	HSBC Global Asset Management (UK) Limited	145,518	3,463	2/29/2024
0.08435 %	JP Morgan Asset Management	140,510	419	3/31/2024
0.07878 %	Storebrand Kapitalforvaltning AS	131,226	5,752	2/29/2024
0.07804 %	ÖKOWORLD LUX S.A.	130,000	-70,000	12/31/2023
0.07550 %	Edelweiss Asset Management Ltd.	125,771	-47,847	3/31/2024
0.07404 %	Franklin Templeton Portfolio Advisors, Inc	123,334	9,978	3/31/2024
0.07384 %	Mahindra Manulife Investment Management Private Limited	123,000	0	3/31/2024
0.07223 %	BlackRock Investment Management (UK) Ltd.	120,327	-2,000	2/29/2024
0.07015 %	UBS Asset Management (Switzerland)	116,847	-2,320	2/29/2024
0.06683 %	DSP Investment Managers Pvt. Ltd.	111,323	2,472	3/31/2024
0.06650 %	Causeway Capital Management LLC	110,779	70	12/31/2023
0.06573 %	Vestcor Inc	109,499	-27,608	12/31/2022
0.06423 %	CPP Investment Board	107,000	44,000	3/31/2023
0.06280 %	Fisher Investments	104,615	8,063	2/29/2024
0.06239 %	DWS Investment GmbH	103,927	0	2/29/2024
0.06195 %	TOBAM	103,188	-3,275	2/29/2024
0.06040 %	Nordea Investment Management AB (Denmark)	100,611	0	2/29/2024
0.05815 %	UBS Asset Management (UK) Ltd.	96,866	37	3/31/2024
0.05562 %	Schroder Investment Management North America Inc.	92,652	53,179	2/29/2024
0.05442 %	State Street Global Advisors (US)	90,647	-21	3/31/2024
0.05405 %	Aditya Birla Sun Life AMC Limited	90,031	3,353	3/31/2024
0.05311 %	Van Eck Associates Corporation	88,475	13,557	3/31/2024
0.05035 %	Pictet Asset Management Ltd.	83,871	-2,747	12/31/2023
0.05005 %	Eastspring Investments (Singapore) Limited	83,367	3,363	1/31/2024
0.04893 %	Robeco Hong Kong Limited	81,504	0	2/29/2024
0.04866 %	Zürcher Kantonalbank (Asset Management)	81,049	1,363	2/29/2024
0.04842 %	Amundi Japan Ltd.	80,657	0	8/31/2023
0.04669 %	PGGM Vermogensbeheer B.V.	77,773	11,700	7/31/2023
0.04644 %	Frostrow Capital LLP	77,366	0	12/31/2023
0.04641 %	Mirae Asset Global Investments (Hong Kong) Limited	77,311	0	11/30/2023
0.04544 %	L&T Investment Management Limited	75,700	0	3/31/2024
0.04440 %	SEB Investment Management AB	73,955	-19,599	2/29/2024
0.04327 %	BlackRock (Singapore) Limited	72,079	26,040	3/31/2024
0.04263 %	Mercer Global Investments Management Ltd	71,011	5,791	3/31/2024
0.04222 %	Credit Suisse Funds AG	70,330	0	3/31/2024
0.04133 %	Caisse de Depot et Placement du Quebec	68,839	27,165	12/31/2022
0.04107 %	Macquarie Investment Management	68,406	-2,253	3/31/2024
0.03853 %	KLP Fondsforvaltning AS	64,185	-3,110	2/29/2024
0.03702 %	Handelsbanken Kapitalförvaltning AB	61,669	0	3/31/2024
0.03581 %	Raiffeisen Kapitalanlage-Gesellschaft mbH	59,656	626	1/31/2024
0.03535 %	Wellington Management Company, LLP	58,877	0	2/29/2024
0.03507 %	Fideuram Asset Management (Ireland) dac	58,422	-290	2/29/2024
0.03492 %	California State Teachers Retirement System	58,169	42,069	6/30/2023
0.03492 %	Motilal Oswal Asset Management Company Ltd.	58,163	8,295	3/31/2024
0.03482 %	Bellevue Asset Management AG	58,000	28,000	2/29/2024
0.03416 %	Dimensional Fund Advisors, Ltd.	56,904	0	2/29/2024
0.03397 %	Mirae Asset Global Investments Co., Ltd.	56,589	280	1/31/2024
0.03392 %	Principal Asset Management Pvt. Ltd.	56,500	0	3/31/2024
0.03342 %	Sophus Capital	55,676	-85	12/31/2023
0.03329 %	Epoch Investment Partners, Inc.	55,448	16,284	12/31/2023
0.03308 %	BI Asset Management Fondsmæglerselskab A/S	55,102	1,439	2/29/2024
0.03241 %	First Trust Advisors L.P.	53,993	7,904	2/29/2024
0.03177 %	Danske Bank Asset Management	52,918	0	3/31/2024
0.03150 %	SEI Investments Management Corporation	52,478	-1,845	3/31/2024
0.03147 %	Legal & General Investment Management Ltd.	52,418	0	3/31/2024

What values and corporate philosophy does Dr Reddy's Laboratories represent?

Dr.Reddy's Laboratories Ltd represents the values of integrity, excellence, and innovation. With a strong corporate philosophy focused on making quality healthcare accessible to all, the company strives to improve the lives of patients globally. Dr.Reddy's Laboratories is committed to conducting business in an ethical and responsible manner, prioritizing patient safety, and adhering to the highest standards of quality in pharmaceutical products. Through continuous research and development, they aim to bring innovative solutions to healthcare challenges and contribute towards a healthier society.

In which countries and regions is Dr Reddy's Laboratories primarily present?

Dr.Reddy's Laboratories Ltd is primarily present in several countries and regions. The company has a widespread global presence and operates in various key markets. Some of the countries and regions where Dr.Reddy's Laboratories Ltd has a significant presence include India, the United States, Europe, Russia, China, and many others. With its extensive reach, Dr.Reddy's Laboratories Ltd has established a strong foothold in the global pharmaceutical industry, catering to diverse markets and delivering innovative healthcare solutions around the world.

What significant milestones has the company Dr Reddy's Laboratories achieved?

Dr.Reddy's Laboratories Ltd, a leading pharmaceutical company, has achieved several remarkable milestones. Firstly, the company successfully launched various generic drugs, consolidating its position in the global market. Additionally, Dr.Reddy's Laboratories Ltd established itself as a pioneer in drug innovation, securing numerous product patents worldwide. Moreover, the company received several prestigious awards, applauding its excellence in research and development. Dr.Reddy's Laboratories Ltd expanded its global footprint by entering into strategic alliances and acquisitions, fostering international growth. Lastly, the company consistently focuses on improving patient healthcare outcomes, ensuring affordable and accessible medication options worldwide. Overall, Dr.Reddy's Laboratories Ltd demonstrates an impressive track record of accomplishments in the pharmaceutical industry.

What is the history and background of the company Dr Reddy's Laboratories?

Dr. Reddy's Laboratories Ltd is a renowned Indian pharmaceutical company, founded in 1984 by Dr. Kallam Anji Reddy. The company has grown into one of the leading integrated pharmaceutical firms globally. Dr. Reddy's Laboratories Ltd specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generic drugs, branded generics, over-the-counter medications, and active pharmaceutical ingredients (APIs). With a strong focus on research and development, the company has established a significant presence in numerous markets worldwide. Dr. Reddy's Laboratories Ltd has received several accolades for its innovative and cost-effective healthcare solutions, contributing to the well-being of individuals across the globe.

Who are the main competitors of Dr Reddy's Laboratories in the market?

Some of the main competitors of Dr. Reddy's Laboratories Ltd in the market include Sun Pharmaceutical Industries Ltd, Lupin Limited, Cipla Ltd, and Torrent Pharmaceuticals Ltd. These companies are also prominent players in the pharmaceutical industry and compete with Dr. Reddy's Laboratories Ltd in the production and distribution of generic and branded drugs.

In which industries is Dr Reddy's Laboratories primarily active?

Dr.Reddy's Laboratories Ltd is primarily active in the pharmaceutical industry.

What is the business model of Dr Reddy's Laboratories?

Dr. Reddy's Laboratories Ltd operates as a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company's business model revolves around the development and commercialization of generic drugs, active pharmaceutical ingredients (APIs), and differentiated formulations. Dr. Reddy's Laboratories leverages its expertise in drug discovery, process chemistry, and formulation technologies to provide affordable and high-quality healthcare solutions to patients worldwide. With a strong focus on research and development, strategic partnerships, and global market presence, Dr. Reddy's Laboratories continues to contribute to the healthcare industry by delivering innovative and cost-effective pharmaceutical products.

What is the P/E ratio of Dr Reddy's Laboratories 2024?

The Dr Reddy's Laboratories P/E ratio is 19.58.

What is the P/S ratio of Dr Reddy's Laboratories 2024?

The Dr Reddy's Laboratories P/S ratio is 3.9.

What is the AlleAktien quality score of Dr Reddy's Laboratories?

The AlleAktien quality score for Dr Reddy's Laboratories is 9/10.

What is the revenue of Dr Reddy's Laboratories 2024?

The Dr Reddy's Laboratories revenue is 280.11 B INR.

How high is the profit of Dr Reddy's Laboratories 2024?

The Dr Reddy's Laboratories profit is 55.78 B INR.

What is the business model of Dr Reddy's Laboratories

Dr. Reddy's Laboratories Ltd. is a multinational pharmaceutical company based in Hyderabad, India. The company specializes in the manufacturing, development, marketing, and distribution of generics, biosimilars, and innovative pharmaceutical products for global markets. The core business of Dr. Reddy's is the production of generics, which are affordable, imitation versions of original drugs. They serve as cost-effective alternatives to expensive branded medications in many countries. The company offers a wide range of generic products and caters to various therapeutic areas such as gastroenterology, cardiology, oncology, neurology, rheumatology, dermatology, and more. Another important segment of the business is the development and marketing of biosimilars. Biosimilars are biologically produced drugs that resemble the composition, effectiveness, and safety of the original product. Dr. Reddy's has a strong pipeline of biosimilars for various diseases such as cancer, autoimmune diseases, and diabetes. The company also heavily invests in innovation. It has developed a range of innovative products that can be used to treat diseases like depression, schizophrenia, and Parkinson's. This includes a long-acting atypical antipsychotic, a low-dose antidepressant, and a neuroprotective drug. In addition to its core business segments, Dr. Reddy's also participates in the marketing of active pharmaceutical ingredients (APIs). The company distributes GMP-certified API products to customers worldwide. The product range includes chemical and biological agents used in various therapeutic areas. Dr. Reddy's products are available in over 100 countries worldwide. The company is committed to meeting the ongoing need for affordable medications while ensuring that patients receive high-quality products. It employs over 20,000 employees globally and collaborates with numerous partners and domestic pharmaceutical companies to achieve its vision. Overall, the activities of Dr. Reddy's Laboratories Ltd. are diverse, encompassing the production and distribution of generics, biosimilars, innovative pharmaceutical products, and APIs. The company has a strong global presence and plays a leading role in the pharmaceutical industry. With its extensive experience and commitment to providing affordable medications, Dr. Reddy's is well-positioned to promote growth in the pharmaceutical industry and the well-being of patients worldwide.

What is the Dr Reddy's Laboratories dividend?

Dr Reddy's Laboratories pays a dividend of 30 INR distributed over payouts per year.

How often does Dr Reddy's Laboratories pay dividends?

The dividend cannot currently be calculated for Dr Reddy's Laboratories or the company does not pay out a dividend.

What is the Dr Reddy's Laboratories ISIN?

The ISIN of Dr Reddy's Laboratories is INE089A01023.

What is the Dr Reddy's Laboratories WKN?

The WKN of Dr Reddy's Laboratories is 659157.

What is the Dr Reddy's Laboratories ticker?

The ticker of Dr Reddy's Laboratories is DRREDDY.NS.

How much dividend does Dr Reddy's Laboratories pay?

Over the past 12 months, Dr Reddy's Laboratories paid a dividend of 40 INR . This corresponds to a dividend yield of about 0.61 %. For the coming 12 months, Dr Reddy's Laboratories is expected to pay a dividend of 43.54 INR.

What is the dividend yield of Dr Reddy's Laboratories?

The current dividend yield of Dr Reddy's Laboratories is 0.61 %.

When does Dr Reddy's Laboratories pay dividends?

Dr Reddy's Laboratories pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Dr Reddy's Laboratories?

Dr Reddy's Laboratories paid dividends every year for the past 0 years.

What is the dividend of Dr Reddy's Laboratories?

For the upcoming 12 months, dividends amounting to 43.54 INR are expected. This corresponds to a dividend yield of 0.66 %.

In which sector is Dr Reddy's Laboratories located?

Dr Reddy's Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dr Reddy's Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dr Reddy's Laboratories from 8/28/2024 amounting to 40 INR, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did Dr Reddy's Laboratories pay the last dividend?

The last dividend was paid out on 8/28/2024.

What was the dividend of Dr Reddy's Laboratories in the year 2023?

In the year 2023, Dr Reddy's Laboratories distributed 40 INR as dividends.

In which currency does Dr Reddy's Laboratories pay out the dividend?

The dividends of Dr Reddy's Laboratories are distributed in INR.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

0.37	0.38	0.33	5.24	7.28	4.5	9.36	9.8	18.61	7.43	5.61	6.58	5.73	18.11	22.11	34.17	39.6	39.89	18.07	20.9	24.63	25.62	34.39	44.21	61.64	81.31
1.42	1.28	2.85	4.05	3.72	4	3.82	5.1	7.81	6.52	14.41	11.6	17.61	25.37	31.8	33.25	40.7	41.25	37.99	40.53	39.87	50.28	49.64	66.76	72.49	80.3
0.39	0.56	0.83	0.95	1.4	1.77	2.8	5.05	3.6	5.01	3.48	4.37	5.07	1.23	1.55	10.65	10.54	10.3	11.21	13.53	11.59	10.6	11.7	11.32	15.51	18.53
0.74	0.7	1.58	2.2	2.78	3.02	3.53	6.67	7.47	11.02	13.25	13.39	15.99	19.43	21.71	24.19	25.53	25.58	28.53	29.09	33.58	35.07	45.41	50.88	48.67	63.55
0.43	0.54	0.95	0	0	0	0	0	0	0.36	2.06	2.26	3.75	5.85	8.75	1	1.73	0.92	1.04	0.94	1.44	4.43	4.37	4.65	5.95	4.36
3.35	3.45	6.53	12.43	15.18	13.29	19.5	26.62	37.49	30.34	38.8	38.2	48.15	69.99	85.91	103.26	118.1	117.94	96.84	104.98	111.1	125.99	145.5	177.82	204.26	248.05
1.77	1.89	3.26	4.34	4.64	5.7	7.09	8.9	11.93	15.17	20.63	25.01	29.02	32.82	37.07	43.88	46.95	52.76	56.38	57.41	53.85	52.14	56.86	61.67	66.29	76
0.61	1.41	0.79	0.03	0.01	4.15	1.32	1.34	1.34	4.82	0.52	3.58	0.01	0.01	0	0	3.9	3.46	6.98	4.75	3.51	3.27	8.44	8.09	5.42	5.72
0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.85	0.72	1.4	1.56	1.43	5.65	4.27	6.89	3.77	3.85	2.89	4.67
0.03	0.03	0.05	0.08	0.83	0.83	0.54	6.31	5.86	5.57	4.7	2.87	4.53	-21.57	-23.42	2.96	7.8	15.95	41.41	41.64	42.73	26.8	35.25	27.01	30.72	36.95
0	0	0	0.24	0.65	0.9	0.78	20.1	20.46	21.07	8.23	3.27	6.06	29.95	32.51	5.95	4.32	4.65	4.76	5.33	4.66	4.91	5.6	5.47	5.47	5.5
0	0	0	0.07	0.04	0.04	0.01	0.03	0.1	0.15	0.38	0.68	1.87	1.34	1.95	3.52	8.19	7.54	10.37	5.68	4.53	12.25	10.75	13.56	7.79	11.75
2.4	3.33	4.1	4.76	6.17	11.61	9.75	36.68	39.69	46.78	34.47	35.4	41.48	43.25	48.96	57.04	72.55	85.9	121.33	120.46	113.56	106.26	120.67	119.65	118.6	140.59
5.75	6.78	10.63	17.19	21.34	24.9	29.24	63.3	77.18	77.12	73.26	73.61	89.63	113.24	134.87	160.3	190.65	203.84	218.17	225.44	224.66	232.25	266.17	297.47	322.85	388.64

265	265	317	383	383	383	383	383	840	841	842	844	846	848	849	851	852	853	829	830	830	831	832	832	833	834
1.58	1.58	2.01	7.73	7.73	7.73	7.73	7.88	17.52	17.64	17.81	18.04	18.28	18.53	18.82	19.16	19.59	20.02	4.78	5.21	5.63	5.92	6.31	6.7	7.11	8.19
1.99	2.5	3.2	6	9.19	11.28	11.17	12.2	21.04	24.67	14.26	15.49	17.35	27.64	39.92	55.97	85.72	102.81	112.24	117.78	133.52	150.15	165.6	183.43	224.56	272.55
0	0	0	0	0	0	0.13	0.23	0.58	1.82	2.34	3.39	3.85	2.87	4.11	2.68	2.17	2.01	4.77	1.89	0.79	0.1	5.64	2.76	1.63	1.97
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
3.84	4.35	5.53	14.11	17.31	19.39	19.42	20.69	39.97	44.97	35.26	37.77	40.32	49.89	63.69	78.65	108.33	125.7	122.62	125.72	140.77	156.99	178.38	193.73	234.13	283.54
0.63	0.45	0.99	1.97	2.52	3.75	4.75	8.46	9.8	10.28	15.06	16.68	6.35	7.57	9.66	8.93	8.49	9.07	10.57	13.35	13.67	15.25	18.11	22.66	22.68	26.14
0	0.03	0.03	0	0	0	0	0.02	0.01	0.01	0.01	0	0.01	0.06	0.02	11.17	12.44	16.35	15.39	17.15	18.37	21.44	21.4	24.04	28.02	29.71
0.17	0.21	0.32	0.39	0.62	0.64	1.91	2.18	1.43	1.23	2.05	3.57	17.41	22.4	27.92	13.79	13.99	15.23	14.5	12.82	10.55	14.66	17.52	22.86	22.82	26
0	0	0	0.09	0.09	0	0.14	0	0	0	0	0	18.32	15.89	18.99	20.61	21.86	22.72	43.63	25.56	12.13	16.53	23.15	27.08	7.39	12.72
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.41	6.96	0.11	0.11	0.06	4.26	4.27	0.86	1.02	4.8	1.31
0.8	0.68	1.34	2.44	3.23	4.39	6.8	10.66	11.23	11.51	17.11	20.25	42.09	45.91	56.59	57.9	63.73	63.47	84.2	68.94	58.97	72.14	81.04	97.66	85.72	95.88
1.11	1.75	3.75	0.18	0.38	0.69	2.8	31.17	24.91	19.68	19.98	14.84	5.37	16.42	12.66	20.76	14.31	10.69	5.45	25.09	22	1.3	6.3	5.75	1.28	5.99
0	0	0	0.37	0.43	0.43	0.22	0.78	1.06	0.96	0.91	0.75	1	0.19	1.07	1.24	0.79	0.54	1.62	1.95	0.47	0.02	0.29	0.01	0.76	0.84
0	0	0	0	0	0	0	0	0	0	0	0	0.86	0.83	0.86	1.74	3.48	3.45	4.28	3.75	2.97	2.8	2.13	1.93	2.23	3.38
1.11	1.75	3.75	0.54	0.81	1.12	3.02	31.95	25.97	20.64	20.89	15.59	7.23	17.44	14.59	23.74	18.58	14.67	11.35	30.79	25.45	4.12	8.71	7.69	4.27	10.21
1.91	2.43	5.1	2.98	4.04	5.51	9.83	42.61	37.2	32.15	38	35.84	49.31	63.35	71.18	81.64	82.32	78.14	95.54	99.73	84.42	76.27	89.75	105.35	89.99	106.09
5.75	6.78	10.63	17.09	21.34	24.9	29.24	63.3	77.17	77.12	73.26	73.61	89.63	113.24	134.87	160.3	190.65	203.84	218.17	225.44	225.19	233.26	268.14	299.07	324.12	389.63

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.6	0.67	1.76	4.61	4.11	2.71	0.14	2.01	12.4	5.45	-6.56	6.18	11.83	18.04	21.65	26.46	29	28.59	15.54	13.5	23.36	18.86	28.84	30.61	60.49
0.1	0.13	0.43	0.52	0.75	1.03	1.26	1.62	3.79	4.02	4.98	4.13	3.98	5.18	5.5	6.48	7.6	9.39	10.27	10.77	11.35	11.63	12.29	11.65	12.5
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.32	2.44
-0.33	-0.32	-1.64	-1.64	-0.61	-0.13	1.04	-2.51	-4.8	-5.56	-8.25	-4.21	-9.58	-13.49	-18.5	-17.19	-20.3	-7.04	-11.02	-11.73	-3	-14.64	-14	-21.26	-18.57
0.11	0.14	0.42	1.03	-0.03	-0.21	-0.14	-0.02	1.2	1.22	15.82	7.04	1.32	6.39	5.13	3.95	8.94	1.69	6.66	5.48	-3	13.99	8.58	7.1	4.46
0.11	0.14	0.4	0.17	0.04	0.02	0.11	0.63	1.54	0.96	1.07	0.32	0.31	1.11	1.26	1.16	1.09	0.92	0.92	1.33	1.61	1.61	1.32	1.35	1.85
0.06	0.1	0.27	0.46	0.68	0.32	-0.04	0.19	1.83	1.53	2.79	2.83	2.99	4.55	5.55	7.14	5.46	7.01	5.77	2.76	4.84	7.11	5.72	7.44	10.71
0.48	0.62	0.96	4.52	4.22	3.39	2.3	1.11	12.59	5.13	5.99	13.15	7.55	16.13	13.78	19.7	25.24	32.63	21.45	18.03	28.7	29.84	35.7	28.11	58.88
-735	-249	-439	-1,568	-1,756	-2,111	-1,741	-1,894	-4,482	-5,092	-6,419	-4,305	-11,539	-8,814	-7,557	-10,831	-15,315	-14,816	-40,931	-11,043	-8,376	-6,115	-12,561	-19,049	-18,866
-852	-1,141	-723	-1,468	-1,828	-6,011	939	-27,614	-4,149	-8,104	-5,050	-7,102	-8,988	-18,884	-14,463	-16,941	-22,647	-20,394	-18,404	-14,883	-7,727	-4,923	-22,660	-26,387	-41,373
-0.12	-0.89	-0.28	0.1	-0.07	-3.9	2.68	-25.72	0.33	-3.01	1.37	-2.8	2.55	-10.07	-6.91	-6.11	-7.33	-5.58	22.53	-3.84	0.65	1.19	-10.1	-7.34	-22.51
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.5	0.64	-0.2	-3.75	0.08	0.31	2.12	27.88	-7.82	-6.07	-0.85	-3.78	8.86	7.21	2.4	3.9	0.34	-11.98	16.31	0.88	-15.18	-19.17	6.09	2.74	-20.4
0	0	0	5.78	0	0	0	0.07	10.03	0.02	0.01	0.02	0.03	0.01	0	0	0.01	0	-15.69	0	-0.54	-0.47	-0.92	0.33	0.37
0.41	0.55	-0.34	1.47	-0.15	-0.14	1.58	26.88	0.23	-7.75	-2.65	-5.32	0.45	3.89	-1.57	-0.24	-4.33	-17	-3.69	-4.44	-21.33	-25.16	-0.3	-2.42	-26.86
-	-	-	-	-39.00	-20.00	-108.00	-628.00	-1,537.00	-958.00	-1,071.00	-321.00	-307.00	-1,111.00	-1,257.00	-1,162.00	-1,090.00	-916.00	-923.00	-1,331.00	-1,607.00	-1,608.00	-1,321.00	-1,345.00	-1,853.00
-87	-88	-138	-562	-191	-432	-432	-436	-437	-737	-738	-1,232	-8,141	-2,216	-2,715	-2,980	-3,587	-4,106	-3,390	-3,992	-4,002	-3,916	-4,147	-4,146	-4,979
0.05	0.03	-0.1	4.63	2.16	-2.79	4.86	0.44	8.81	-11.16	-1.82	0.98	-0.85	1.63	-2.16	3.42	-2.8	-0.47	-1.14	-1.24	-0.31	-0.27	12.86	0.03	-9.07
-251	374	522	2,956	2,466	1,282	558	-789	8,107	36	-428	8,845	-3,985	7,312	6,222	8,866	9,920	17,810	-19,486	6,987	20,328	23,726	23,142	9,059	40,009
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Scope 1 - Direct Emissions	214,257
Scope 2 - Indirect emissions from purchased energy	137,627
Scope 3 - Indirect emissions within the value chain	921,055.271
Total CO₂ emissions	351,884
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	✅
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	✅
Environmentally friendly packaging	✅
Hazardous substances	✅
Fuel consumption and efficiency	❌
Water consumption and efficiency	✅

Percentage of female employees	18.97
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	✅
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Environmental reporting	✅
Stakeholder Engagement	✅
Call Back Policies	✅
Antitrust law	❌

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e	2028e
4.26	4.93	9.84	16.88	17.29	19.33	18.42	23.63	65.26	49.92	69.01	70.31	74.97	98.15	118.96	134.15	150.23	155.68	141.96	142.81	154.48	175.17	190.48	215.45	246.7	280.11	314.89	340.53	331.63	372.73
-	15.75	99.61	71.56	2.40	11.83	-4.72	28.26	176.19	-23.51	38.24	1.89	6.63	30.91	21.20	12.78	11.99	3.63	-8.81	0.60	8.17	13.39	8.74	13.11	14.50	13.54	12.42	8.14	-2.61	12.40
59.85	63.67	63.71	73.40	70.46	66.88	66.01	63.27	56.21	63.04	62.89	63.70	69.20	69.75	66.57	68.70	70.70	71.33	70.36	68.35	67.77	65.68	65.54	62.88	66.34	68.08	-	-	-	-
2.55	3.14	6.27	12.39	12.18	12.93	12.16	14.95	36.68	31.47	43.4	44.79	51.88	68.46	79.18	92.16	106.21	111.05	99.88	97.61	104.69	115.04	124.83	135.48	163.65	190.71	0	0	0	0
0.65	0.76	1.98	4.37	3.64	1.94	-0.33	1.52	12.85	4.39	9.56	10.14	11.55	19.17	21.73	26.03	27.48	30.8	14.9	12.74	20.55	29.91	33.22	35.33	52.9	64.63	71.39	73.72	59.22	85.85
15.21	15.42	20.15	25.91	21.06	10.03	-1.80	6.42	19.69	8.79	13.86	14.42	15.41	19.53	18.26	19.41	18.29	19.78	10.50	8.92	13.30	17.07	17.44	16.40	21.44	23.07	22.67	21.65	17.86	23.03
0.52	0.6	1.45	4.58	3.64	2.52	0.33	1.47	9.66	4.38	-9.17	3.52	9.99	13.01	15.27	19.63	23.36	21.31	12.92	9.47	19.5	20.26	19.52	21.83	45.07	55.78	58.23	60.73	49.59	0
-	16.41	139.64	216.89	-20.46	-30.94	-86.92	345.90	558.42	-54.64	-309.36	-138.32	184.18	30.23	17.36	28.58	19.01	-8.81	-39.36	-26.72	105.96	3.90	-3.67	11.83	106.52	23.75	4.40	4.29	-18.34	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
212	212	212	152	153	153	153	154	160	169	168	170	170	170	171	171	171	171	167	166	166	166	166	166.34	166.39	166.71	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Dr Reddy's Laboratories Ticker	Dr Reddy's Laboratories FIGI
DRRD:IN	BBG000CQNB44
DRRD:IB	BBG000CQNBN3
DRRD:IS	BBG000CQND59
DRRD:IG	BBG003NVWBW4

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

TickerDRREDDY.NS

ISININE089A01023

WKN659157

Dr Reddy's Laboratories stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Dr Reddy's Laboratories Stock Price History

Dr Reddy's Laboratories Revenue, EBIT, Net Income INE089A01023 · 659157

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Dr Reddy's Laboratories Revenue, EBIT and net profit per share

Dr Reddy's Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Dr Reddy's Laboratories stock margins INE089A01023 · 659157

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Dr Reddy's Laboratories Margin History

Dr Reddy's Laboratories Stock Sales Revenue, EBIT, Earnings per Share INE089A01023 · 659157

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Dr Reddy's Laboratories Revenue, EBIT and net profit per share

Dr Reddy's Laboratories business model

Dr Reddy's Laboratories SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Dr Reddy's Laboratories Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Dr Reddy's Laboratories historical P/E ratio, EBIT, and P/S ratio.

Dr Reddy's Laboratories shares outstanding INE089A01023 · 659157

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Dr Reddy's Laboratories Stock splits

Dr Reddy's Laboratories dividend history and estimates INE089A01023 · 659157

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Dr Reddy's Laboratories Dividend History

Dr Reddy's Laboratories dividend payout ratio INE089A01023 · 659157

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
DRREDDY.NS

ISIN
INE089A01023

WKN
659157